Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Equillium, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −5 vs. Q2 2021
- Shares held
- 7.32M
- +214.0K (+3.0%) vs. Q2 2021
- Total value
- $49.9M
- +$8.07M (+19.3%) vs. Q2 2021
- New holders
- 4
- 5 more added
- Sold out
- 9
- 3 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $133.0M |
| Q1 2026 | 50 | $81.0M |
| Q4 2025 | 36 | $54.7M |
| Q3 2025 | 40 | $42.4M |
| Q2 2025 | 27 | $2.74M |
| Q1 2025 | 24 | $3.39M |
| Q4 2024 | 26 | $6.52M |
| Q3 2024 | 26 | $7.25M |
| Q2 2024 | 25 | $6.15M |
| Q1 2024 | 28 | $20.5M |
| Q4 2023 | 25 | $6.85M |
| Q3 2023 | 25 | $6.75M |
| Q2 2023 | 27 | $7.44M |
| Q1 2023 | 28 | $7.86M |
| Q4 2022 | 31 | $13.3M |
| Q3 2022 | 30 | $28.4M |
| Q2 2022 | 25 | $25.6M |
| Q1 2022 | 30 | $39.7M |
| Q4 2021 | 26 | $27.0M |
| Q3 2021 | 22 | $49.9M |
| Q2 2021 | 28 | $41.9M |
| Q1 2021 | 33 | $54.6M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Equillium, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 15 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 225 | $1.00K | 0.00% | −163−42.0% | Reduced |
| US Bancorp | 494 | $3.00K | 0.00% | 00.0% | Unchanged |
| Koshinski Asset Management, Inc. | 1,000 | $6.82K | 0.00% | +1,000 | New |
| Wells Fargo & Company | 1,112 | $8.00K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 10,909 | $74.0K | 0.00% | +10,909 | New |
| United Capital Financial Advisers, LLC | 13,500 | $92.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 14,130 | $96.0K | 0.00% | +14,130 | New |
| Northern Trust Corp | 34,055 | $232.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 42,791 | $292.0K | 0.00% | −689−1.6% | Reduced |
| State Street Corp | 49,656 | $339.0K | 0.00% | +18,900+61.5% | Added |
| Two Sigma Securities, LLC | 83,948 | $573.0K | 0.12% | +83,948 | New |
| Bridgeway Capital Management, LLC | 106,200 | $724.0K | 0.01% | −35,000−24.8% | Reduced |
| Geode Capital Management, LLC | 154,185 | $1.05M | 0.00% | +3,603+2.4% | Added |
| DCF Advisers, LLC | 185,666 | $1.27M | 0.69% | +108,128+139.5% | Added |
| FMR LLC | 209,800 | $1.43M | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 356,461 | $2.43M | 0.00% | 00.0% | Unchanged |
| Tang Capital Management LLC | 600,000 | $4.09M | 0.85% | 00.0% | Unchanged |
| Franklin Resources Inc | 700,000 | $4.77M | 0.00% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 738,176 | $5.03M | 0.84% | 00.0% | Unchanged |
| Vanguard Group Inc | 850,077 | $5.80M | 0.00% | +9,532+1.1% | Added |
| Victory Capital Management Inc | 3,170,199 | $21.6M | 0.02% | +273,324+9.4% | Added |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −218,162−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −44,238−100.0% | Sold out |
| First Republic Investment Management, Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −531−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −341−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −166−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |